SCHEDULE 13G: Arena Investors Discloses 9.0% Stake in Firefly Neuroscience Following Convertible Note Conversion

Arena Investors and its affiliates have disclosed a 9.0% beneficial ownership stake in Firefly Neuroscience, Inc., acquiring 800,000 shares through the conversion of a convertible promissory note.

Summary

• Arena Investors, LP, along with its affiliates Arena Investors GP, LLC, Arena SPV Manager, LLC, and Helena Special Opportunities, LLC, have filed a Schedule 13G disclosing beneficial ownership of common stock in Firefly Neuroscience, Inc.
• The reporting persons collectively beneficially own 800,000 shares of Firefly Neuroscience, Inc. Common Stock.
• This ownership represents 9.0% of the company's outstanding common stock.
• The shares were acquired by Helena Special Opportunities, LLC on February 13, 2025, through the conversion of a convertible promissory note.
• The percentage of beneficial ownership is calculated based on 8,071,520 shares outstanding as of February 5, 2025, as reported by Firefly Neuroscience, Inc. in its Form S-1 filed on February 7, 2025.
• The filing indicates that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The filing is a factual disclosure of a significant ownership stake resulting from a convertible note conversion. While not directly a positive or negative performance report, the conversion of debt to equity can be viewed as a positive step for the company's balance sheet and an affirmation of investor confidence.

Positives

• A significant investment firm, Arena Investors, has converted a convertible note into equity, indicating a long-term commitment to Firefly Neuroscience, Inc.
• The conversion of the convertible promissory note strengthens the capital structure of Firefly Neuroscience by converting debt into equity.

Future Outlook

This document, a Schedule 13G, is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from the company or the reporting persons regarding future operations or financial performance.

Management Comments

• The filing includes a certification from the reporting persons stating: "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

Schedule 13G filings are standard disclosures required by the SEC when an entity acquires beneficial ownership of more than 5% of a class of a company's voting equity securities, and qualifies as a passive investor (owning less than 20% and not intending to influence control). This filing indicates a significant, passive investment by Arena Investors in Firefly Neuroscience, Inc., a company likely in the neuroscience or biotechnology sector given its name. The conversion of a convertible note into equity is a common financing mechanism, often used by growth-stage companies to secure capital with a future equity conversion option.

Stakeholder Impact

• Shareholders: The disclosure of a new 9.0% beneficial owner provides transparency regarding the company's ownership structure. The conversion of a convertible note into equity could dilute existing shareholders, but also strengthens the company's balance sheet by reducing debt.
• Creditors: The conversion of a convertible promissory note into equity reduces the company's debt obligations, which is generally positive for creditors.

Key Dates

Keywords

Firefly Neuroscience, Arena Investors, Schedule 13G, Beneficial Ownership, Common Stock, Convertible Note, Equity Stake, Investment, SEC Filing